Expression of CD28, FAS, PD1, and CTLA4 molecules in the blood of women with triple‐negative breast cancer

Documenti analoghi

• Soluble sFas, sFasL, sPD1, and sPDL1 Analyses in the Peripheral Blood of Locally Advanced Breast Cancer Patients Before and After Neoadjuvant Chemotherapy
  di: Carolina de Souza Vasconcelos, et al.
  Pubblicazione: (2025)
• Prognostic role of SOX2 and STAT3 expression on circulating T lymphocytes and CD44+/CD24neg cells in the locally advanced and metastatic breast cancer
  di: Denise V. Sobral, et al.
  Pubblicazione: (2024)
• Expression of CD44highCD24Low cells, SOX2, and STAT3 transcription factors on peripheral blood and tumor tissue of penile squamous cell carcinoma
  di: Felipe Dubourcq de Barros, et al.
  Pubblicazione: (2024)
• Second primary malignancies in women with breast cancer
  di: Courtney Chen, et al.
  Pubblicazione: (2024)
• Soluble levels of 4‐1BB (CD137) and OX40 (CD134) are associated with cancer progression in gastric adenocarcinoma
  di: Cecilia Araújo Carneiro Lima, et al.
  Pubblicazione: (2024)